Breast Cancer Screening, Cervical Cancer Screening, Colorectal Cancer Screening, Depression
Conditions
Keywords
Depression, Breast Cancer Screening, Cervical Cancer Screening, Colorectal Cancer Screening
Brief summary
Bronx County, New York is the poorest urban county in the U.S.A., and residents are almost entirely Latino or African American. Cancer is the leading cause of premature death in the Bronx, with morality rates significantly higher than for New York City as a whole. Low-income/minority populations are more likely to be diagnosed with preventable and late-stage cancers than the general population, in part, due to lower screening rates. While research has addressed screening barriers in low-income/minority groups, depression, a common,potentially critical barrier, has received scant attention. Research suggests that depressed women are less likely to engage in cancer screening, especially mammography and Pap testing. The link between mental health and cancer screening is particularly important to address in the Bronx, which has the highest rates of self-reported serious psychological distress (a measure closely related to depression) in New York City. Depression affects almost 1 in 4 minority women, and while minorities often seek help for depression in primary care, primary care depression management often does not meet evidence-based standards. Drawing on the expertise and close collaboration of Bronx medical and social service providers and patient stakeholders, this study will determine whether a collaborative care intervention that addresses both depression and cancer screening needs simultaneously among women ages 50-64 is more effective at improving cancer screening and patient-reported outcomes for women with depression than an existing evidence-based cancer screening intervention alone. To achieve this, the investigators will compare the effectiveness of these two interventions using a randomized controlled trial (RCT). In partnership with six Bronx Federally Qualified Health Centers (FQHCs), the investigators will recruit approximately 800 women ages 50-64 who screen positive for depression and are non-adherent with recommended cervical, breast, and/or colorectal cancer screenings. The investigators specific aims are to: 1) compare the impact of the two interventions on patient-reported outcomes, including cancer screening knowledge and attitudes, self-efficacy, depression-related stigma, provider referrals, participation in mental health care, medication adherence, quality of life, satisfaction with care and treatment decisions, and depression; 2) compare the effectiveness of the two interventions in increasing breast, cervical, and colorectal cancer screening; 3) determine whether reducing depression increases the likelihood that low-income women 50-64 will receive cancer screening; 4) determine whether effectiveness of the two interventions in increasing cancer screening varies according to patient characteristics, such as duration of depression, presence of other chronic conditions, and obesity. This study is designed to increase the investigators understanding of how to enhance primary care systems' ability to improve a range of outcomes related to cancer screening and depression among low-income minority women, and how to best support this population in making cancer-screening decisions.
Interventions
BEHAVIORALPrevention Care Management for Depression and Cancer Screening
BEHAVIORALPrevention Care Management for Cancer Screening
Sponsors
Clinical Directors Network
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
50 Years to 64 Years
Healthy volunteers
No
Inclusion criteria
* Resident of the Bronx * Overdue for breast, cervical or colorectal cancer screening * Screen positive for depression * No cancer diagnosis within the past six months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Assessment of Colorectal, Breast, and Cervical Cancer Screening Up to Date Status | Baseline - 12 months | Comparison of the proportion of patients who were up to date for colorectal cancer, breast cancer and cervical cancer screenings before and after the intervention. (Chart Review) |
| Assessment of Colorectal Cancer Screening Up to Date Status After Intervention | Baseline - 12 months | Multivariate logistic regression model was used to assess which factors contributed to colorectal cancer screening up to date status. |
| Assessment of Breast Cancer Screening Up to Date Status After Intervention | Baseline - 12 months | Multivariate logistic regression model was used to assess which factors contributed to breast cancer screening up to date status |
| Assessment of Cervical Cancer Screening Up to Date Status After Intervention | Baseline - 12 months | Multivariate logistic regression model was used to assess which factors contributed to cervical cancer screening up to date status |
| Comparison of Change in Patient Health Questionnaire-9 (PHQ9) Score by Intervention Arm | Baseline - 12 months | Comparison of change in depression between the CCI and PCM arm before and after intervention. (Self-Report). The Patient Health Questionnaire-9 (PHQ9) is a well-validated measure of Diagnostic and Statistical Manual of Mental Disorders 4th Edition (DSM-IV) criteria for screening and diagnosing depressive episode, assessing severity, and monitoring treatment response. The PHQ9 score ranges from the minimum of 0 (no depression) to the maximum of 27 (severe depression). The detailed PHQ9 scores and corresponding level of depression severity are as follow: 0 (no depression), 1-4 (mild depression), 5-9 (medium-mild depression), 10-14 (moderate depression), 15-19 (moderately severe depression) and 20-27 (severe depression). The mean change in PHQ9 score is the mean of the differences between PHQ9 score at baseline and the PHQ9 score at follow up for all cases in the respective intervention arm; the greater the change in PHQ9 score, the greater the improvement in depression severity. |
| Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 6 Months | Baseline - 6 months | The SCL-20 consists of the 20 depression items on a 4-point scale from the SCL-90, and has been shown to be a valid and reliable measure of depression in diverse outpatient and community populations. |
| Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 12 Months | Baseline - 12 months | The SCL-20 consists of the 20 depression items on a 4-point scale from the SCL-90, and has been shown to be a valid and reliable measure of depression in diverse outpatient and community populations. |
| Changes From Baseline in Number of Participants With Colorectal, Breast, and/or Cervical Cancer Screening | Baseline - 12 months | Self-Report: We will ask participants about their participation (yes/no) in specific screening methods: Pap testing (past 3 years), mammography (past 2 years), and colorectal screening (fecal occult blood tests (FOBT)/fecal immunohistochemical tests (FIT)), past year; flexible sigmoidoscopy, the past 5 years; and colonoscopy, past 10 years). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Devaluation-Discrimination Scale | Baseline and 12 months | This measure was adapted from the Link's Devaluation-Discrimination Scale.The continuous summary score was converted into 4 categories using quartiles as cut points. The 4 categories were as follows: Low stigma, minimal stigma, moderate stigma and high stigma. |
| Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Baseline, 6 months and 12 months | The Ambulatory Care Experiences Survey produces 11 summary measures covering 2 broad dimensions of patients' experiences: quality of physician-patient interactions and organizational features of care. The continuous summary score was converted into 4 categories (High, Moderate, Fair and Low) using quartiles as cut-points. |
| Mental Health Care Utilization: Assessed by Patient Report | Baseline, 6 months and 12 months | Participants were asked how many times in the past six months they had seen a provider to talk about or to receive medication for feeling sad, nervous, hopeless, or blue. This question was adapted from the NCI's HINTS survey. Two categories were created using the median as a cut point. The two categories were high utilization and low utilization. |
| Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization | Baseline, 6 months and 12 months | This 5-item scale measures a sense of perceived self-efficacy associated with accessing and paying for the three different types of cancer screening and utilization of needed mental health services. The continuous study score was converted into 4 categories using quartiles as cut points. The 4 categories are high self-efficacy, moderate self- efficacy, minimal self-efficacy and low self-efficacy. |
| Medication Adherence | Baseline, 6 months and 12 months | In this questionnaire, respondents were asked if they had been prescribed medication for depression and about difficulties taking medication(s) regularly. Standard cut points was used for medical adherence. High adherence- around an 8. Medium adherence - 6-7.99. Low adherence would be anything less than 6. |
| Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Baseline, 6 months and 12 months | The Satisfaction with Decision Scale is a 6-item measure that uses a five-point Likert-type scale; it is grounded in a conceptual model of an effective decision, i.e., one that is informed, consistent with the decision-maker's values, and behaviorally implemented. This scale has been tailored to healthcare decisions to receive treatment for emotional or mental health and to have cervical, breast, and colon cancer screening.The continuous summary score was converted into two categories using the median as a cut point. The two categories are high satisfaction and low satisfaction. |
| Physician Recommendation of Screening/Mental Health Care | Baseline, 6 months and 12 months | This questionnaire, adopted from National Cancer Institute's (NCI) Health Information National Trends Survey (HINTS), assesses whether patients report that their primary care physician 1) has recommended cervical, breast, and colon cancer screening and 2) has recommended that the patient make an appointment with a mental health provider and/or take psychotropic medication. Two categories were created according to whether the patient received a physician recommendation (yes/no). The category of Recommendation for when they received a recommendation and a category of No Recommendation if they did not receive a recommendation |
| Generalized Anxiety Disorder | Baseline, 6 months and 12 months | This Generalized Anxiety Disorder scale is based on diagnostic criteria in the Diagnostic and Statistical Manual of Mental Disorders 4th Edition (DSM-IV) and measures probable anxiety disorder and severity of anxiety symptoms. Patients are asked to rate how often they have been bothered by 7 problems in the last 2 weeks on a 4-point scale. Standard cut points were used for the Generalized Anxiety Disorder measure. Minimal anxiety is (0-4). Mild Anxiety would be count as (5-9). Moderate Anxiety (10-14) and severe anxiety would be (15-21). |
| Medical Outcomes Study Health Survey-Short Form | Baseline, 6 months and 12 months | The quality of life was measured with the Medical Outcomes Study (MOS) Short Form Health Survey (SF-12) is a general measure of health status that assess the patient's perceived health status and whether health problems interfere with normal functioning. The SF-12 has demonstrated validity and test-retest reliability in the general population and in patients with chronic health conditions, and has been tested in five languages, including Spanish. It has been used extensively as a quality of life measure in collaborative care studies, including with low-income minority populations. It has also been used frequently in screening studies, for cancer and other conditions. The SF-12 has been validated as an indicator of effects of depression on quality of life in ethnically diverse patients. The continuous summary score was converted into 4 categories using quartiles as cutoff points. The four categories are Best Health, Good health, Fair Health and Worst Health. |
| Breast, Cervical and Colorectal Cancer Screening Attitudes | Baseline, 6 months and 12 months | This measure was adapted from the National Cancer Institute's HINTS questions for colorectal cancer. The continuous summary score was converted into 4 categories using quartiles as cut points. The categories for screening attitudes were as follows: positive attitudes, moderate attitudes, fair attitudes and negative attitudes. |
| Satisfaction With Decision Scale- Cancer Screening (Data Reported in Outcome Measure #10) | Baseline, 6 months and 12 months | The Satisfaction with Decision Scale is a 6-item measure that uses a five-point Likert-type scale; it is grounded in a conceptual model of an effective decision, i.e., one that is informed, consistent with the decision-maker's values, and behaviorally implemented. This scale has been tailored to healthcare decisions to have cervical, breast, and colon cancer screening.The satisfaction with decision scale of cancer screening and its continuous summary score was converted into two categories (high satisfaction and low satisfaction) using the median as the cutoff point. |
| Satisfaction With Decision Scale- Mental Health (Data Reported in Secondary Outcome Measure #10) | 12 months | The Satisfaction with Decision Scale is a 6-item measure that uses a five-point Likert-type scale; it is grounded in a conceptual model of an effective decision, i.e., one that is informed, consistent with the decision-maker's values, and behaviorally implemented. This scale has been tailored to healthcare decisions to have mental health care.The satisfaction with decision scale of mental health and its continuous summary score was converted into two categories (high satisfaction and low satisfaction) using the median as the cutoff point. |
Countries
United States
Participant flow
Pre-assignment details
Among the 802 participants who were recruited for the study, 759 completed the baseline assessment and were randomized to one of the two intervention groups. Two participants were found to be ineligible after randomization and were excluded; as a result, 757 participants are included in the analyses.
Participants by arm
| Arm | Count |
|---|---|
| Collaborative Care Intervention (CCI) Participants assigned to the CCI group received the Prevention Care Management (PCM) intervention, as well as motivational support to initiate or follow up on mental health treatment and linkages to social support services. | 378 |
| Prevention Care Management (PCM) Intervention The PCM intervention consisted of cancer screening telephone support, including education, patient navigation, and motivational interviewing to overcome barriers to screening. | 379 |
| Total | 757 |
Baseline characteristics
| Characteristic | Prevention Care Management (PCM) Intervention | Collaborative Care Intervention (CCI) | Total |
|---|---|---|---|
| Age, Continuous | 55.8 years STANDARD_DEVIATION 4.2 | 56.2 years STANDARD_DEVIATION 4.3 | 56.0 years STANDARD_DEVIATION 4.3 |
| Cancer history | 32 Participants | 28 Participants | 60 Participants |
| Cancer Screening Up to date for Breast Cancer Screening | 159 Participants | 166 Participants | 325 Participants |
| Cancer Screening Up to date for Cervical Cancer Screening | 158 Participants | 160 Participants | 318 Participants |
| Cancer Screening Up to date for Colorectal Cancer Screening | 102 Participants | 83 Participants | 185 Participants |
| Comorbid Condition- Asthma | 123 Participants | 124 Participants | 247 Participants |
| Comorbid Condition- Diabetes | 152 Participants | 157 Participants | 309 Participants |
| Comorbid Condition- Hyperlipidemia | 209 Participants | 220 Participants | 429 Participants |
| Comorbid Condition- Hypertension | 245 Participants | 242 Participants | 487 Participants |
| Country of Birth Born in U.S. | 154 Participants | 142 Participants | 296 Participants |
| Country of Birth Born outside of U.S. | 223 Participants | 235 Participants | 458 Participants |
| Education 8-11 years | 131 Participants | 113 Participants | 244 Participants |
| Education Completed High School | 82 Participants | 90 Participants | 172 Participants |
| Education Less than 8 years | 81 Participants | 89 Participants | 170 Participants |
| Education Post High School and higher | 82 Participants | 84 Participants | 166 Participants |
| Employment Employed | 78 Participants | 76 Participants | 154 Participants |
| Employment Homemaker | 59 Participants | 61 Participants | 120 Participants |
| Employment Other | 134 Participants | 139 Participants | 273 Participants |
| Employment Unemployed | 108 Participants | 102 Participants | 210 Participants |
| Ethnicity (NIH/OMB) Hispanic or Latino | 301 Participants | 289 Participants | 590 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 78 Participants | 89 Participants | 167 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 0 Participants | 0 Participants | 0 Participants |
| Household income $0 to $9,999 | 242 Participants | 258 Participants | 500 Participants |
| Household income $10,000 to $14,999 | 69 Participants | 42 Participants | 111 Participants |
| Household income $15,000 or more | 62 Participants | 74 Participants | 136 Participants |
| Hysterectomy | 83 Participants | 84 Participants | 167 Participants |
| Insurance Employer | 17 Participants | 12 Participants | 29 Participants |
| Insurance Medicaid | 285 Participants | 275 Participants | 560 Participants |
| Insurance Medicaid + Medicare | 32 Participants | 32 Participants | 64 Participants |
| Insurance Medicare | 12 Participants | 17 Participants | 29 Participants |
| Insurance No insurance | 33 Participants | 41 Participants | 74 Participants |
| Marital Status Married/cohabitating | 95 Participants | 95 Participants | 190 Participants |
| Marital Status Other | 9 Participants | 10 Participants | 19 Participants |
| Marital Status Single/divorced/widowed/separated | 274 Participants | 271 Participants | 545 Participants |
| Patient Health Questionnaire-9 (PHQ9) Score Group Mild Depression (5-9) | 104 Participants | 104 Participants | 208 Participants |
| Patient Health Questionnaire-9 (PHQ9) Score Group Moderate Depression (10-14) | 147 Participants | 159 Participants | 306 Participants |
| Patient Health Questionnaire-9 (PHQ9) Score Group Moderately Severe Depression (15-19) | 102 Participants | 80 Participants | 182 Participants |
| Patient Health Questionnaire-9 (PHQ9) Score Group Severe Depression (20-27) | 26 Participants | 34 Participants | 60 Participants |
| Primary Language English | 167 Participants | 163 Participants | 330 Participants |
| Primary Language Spanish | 212 Participants | 215 Participants | 427 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Asian | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Black or African American | 67 Participants | 82 Participants | 149 Participants |
| Race (NIH/OMB) More than one race | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 300 Participants | 275 Participants | 575 Participants |
| Race (NIH/OMB) White | 12 Participants | 19 Participants | 31 Participants |
| Region of Enrollment United States | 379 participants | 378 participants | 757 participants |
| Sex: Female, Male Female | 379 Participants | 378 Participants | 757 Participants |
| Sex: Female, Male Male | 0 Participants | 0 Participants | 0 Participants |
| Smoking Status Current | 89 Participants | 92 Participants | 181 Participants |
| Smoking Status Former | 53 Participants | 50 Participants | 103 Participants |
| Smoking Status Never | 178 Participants | 166 Participants | 344 Participants |
| Years receiving care at the community health center before consent < 3 | 138 Participants | 126 Participants | 264 Participants |
| Years receiving care at the community health center before consent ≥ 3 | 239 Participants | 251 Participants | 490 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 5 / 378 | 1 / 379 |
| other Total, other adverse events | 4 / 378 | 4 / 379 |
| serious Total, serious adverse events | 1 / 378 | 0 / 379 |
Outcome results
Primary
Assessment of Breast Cancer Screening Up to Date Status After Intervention
Multivariate logistic regression model was used to assess which factors contributed to breast cancer screening up to date status
Time frame: Baseline - 12 months
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Collaborative Care Intervention (CCI) | Assessment of Breast Cancer Screening Up to Date Status After Intervention | Up to Date at Baseline | 43.9 Percentage of Participants |
| Collaborative Care Intervention (CCI) | Assessment of Breast Cancer Screening Up to Date Status After Intervention | Up to Date at Follow Up | 66.7 Percentage of Participants |
| Prevention Care Management (PCM) | Assessment of Breast Cancer Screening Up to Date Status After Intervention | Up to Date at Baseline | 42.0 Percentage of Participants |
| Prevention Care Management (PCM) | Assessment of Breast Cancer Screening Up to Date Status After Intervention | Up to Date at Follow Up | 66.8 Percentage of Participants |
p-value: 0.850195% CI: [0.753, 1.41]Regression, Logistic
Primary
Assessment of Cervical Cancer Screening Up to Date Status After Intervention
Multivariate logistic regression model was used to assess which factors contributed to cervical cancer screening up to date status
Time frame: Baseline - 12 months
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Collaborative Care Intervention (CCI) | Assessment of Cervical Cancer Screening Up to Date Status After Intervention | Up to Date at Baseline | 42.3 Percentage of participants |
| Collaborative Care Intervention (CCI) | Assessment of Cervical Cancer Screening Up to Date Status After Intervention | Up to Date at Follow Up | 61.6 Percentage of participants |
| Prevention Care Management (PCM) | Assessment of Cervical Cancer Screening Up to Date Status After Intervention | Up to Date at Baseline | 41.7 Percentage of participants |
| Prevention Care Management (PCM) | Assessment of Cervical Cancer Screening Up to Date Status After Intervention | Up to Date at Follow Up | 64.6 Percentage of participants |
p-value: 0.443295% CI: [0.625, 1.228]Regression, Logistic
Primary
Assessment of Colorectal, Breast, and Cervical Cancer Screening Up to Date Status
Comparison of the proportion of patients who were up to date for colorectal cancer, breast cancer and cervical cancer screenings before and after the intervention. (Chart Review)
Time frame: Baseline - 12 months
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Collaborative Care Intervention (CCI) | Assessment of Colorectal, Breast, and Cervical Cancer Screening Up to Date Status | Colorectal Cancer Screening - Follow Up | 56.9 Percentage (%) of Participants |
| Collaborative Care Intervention (CCI) | Assessment of Colorectal, Breast, and Cervical Cancer Screening Up to Date Status | Cervical Cancer Screening - Baseline | 42.3 Percentage (%) of Participants |
| Collaborative Care Intervention (CCI) | Assessment of Colorectal, Breast, and Cervical Cancer Screening Up to Date Status | Breast Cancer Screening - Follow Up | 66.7 Percentage (%) of Participants |
| Collaborative Care Intervention (CCI) | Assessment of Colorectal, Breast, and Cervical Cancer Screening Up to Date Status | Breast Cancer Screening - Baseline | 43.9 Percentage (%) of Participants |
| Collaborative Care Intervention (CCI) | Assessment of Colorectal, Breast, and Cervical Cancer Screening Up to Date Status | Cervical Cancer Screening - Follow Up | 61.6 Percentage (%) of Participants |
| Collaborative Care Intervention (CCI) | Assessment of Colorectal, Breast, and Cervical Cancer Screening Up to Date Status | Colorectal Cancer Screening - Baseline | 22.0 Percentage (%) of Participants |
| Prevention Care Management (PCM) | Assessment of Colorectal, Breast, and Cervical Cancer Screening Up to Date Status | Cervical Cancer Screening - Follow Up | 64.6 Percentage (%) of Participants |
| Prevention Care Management (PCM) | Assessment of Colorectal, Breast, and Cervical Cancer Screening Up to Date Status | Colorectal Cancer Screening - Baseline | 26.9 Percentage (%) of Participants |
| Prevention Care Management (PCM) | Assessment of Colorectal, Breast, and Cervical Cancer Screening Up to Date Status | Colorectal Cancer Screening - Follow Up | 52.8 Percentage (%) of Participants |
| Prevention Care Management (PCM) | Assessment of Colorectal, Breast, and Cervical Cancer Screening Up to Date Status | Breast Cancer Screening - Baseline | 42.0 Percentage (%) of Participants |
| Prevention Care Management (PCM) | Assessment of Colorectal, Breast, and Cervical Cancer Screening Up to Date Status | Breast Cancer Screening - Follow Up | 66.8 Percentage (%) of Participants |
| Prevention Care Management (PCM) | Assessment of Colorectal, Breast, and Cervical Cancer Screening Up to Date Status | Cervical Cancer Screening - Baseline | 41.7 Percentage (%) of Participants |
Comparison: Colorectal Cancer Screening Intervention Arm Differencep-value: 0.2562Chi-squared
Comparison: Breast Cancer Screening Intervention Arm Differencep-value: 0.9795Chi-squared
Comparison: Cervical Cancer Screening Intervention Arm Differencep-value: 0.3917Chi-squared
Primary
Assessment of Colorectal Cancer Screening Up to Date Status After Intervention
Multivariate logistic regression model was used to assess which factors contributed to colorectal cancer screening up to date status.
Time frame: Baseline - 12 months
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Collaborative Care Intervention (CCI) | Assessment of Colorectal Cancer Screening Up to Date Status After Intervention | Up to Date at Baseline | 22.0 percentage of participants |
| Collaborative Care Intervention (CCI) | Assessment of Colorectal Cancer Screening Up to Date Status After Intervention | Up to Date at Follow Up | 56.9 percentage of participants |
| Prevention Care Management (PCM) | Assessment of Colorectal Cancer Screening Up to Date Status After Intervention | Up to Date at Baseline | 26.9 percentage of participants |
| Prevention Care Management (PCM) | Assessment of Colorectal Cancer Screening Up to Date Status After Intervention | Up to Date at Follow Up | 52.8 percentage of participants |
p-value: 0.067795% CI: [0.979, 1.851]Regression, Logistic
Primary
Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 12 Months
The SCL-20 consists of the 20 depression items on a 4-point scale from the SCL-90, and has been shown to be a valid and reliable measure of depression in diverse outpatient and community populations.
Time frame: Baseline - 12 months
Population: This data is collected at baseline and 12 months. Not all participants completed all instruments at all time points.
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Collaborative Care Intervention (CCI) | Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 12 Months | Baseline | Mild to Moderate Depression (0.5 - 1.7) | 198 Participants |
| Collaborative Care Intervention (CCI) | Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 12 Months | Baseline | No Depression (<0.5) | 37 Participants |
| Collaborative Care Intervention (CCI) | Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 12 Months | Baseline | Severe Depression (> 1.7) | 92 Participants |
| Collaborative Care Intervention (CCI) | Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 12 Months | 12 Months | No Depression (<0.5) | 113 Participants |
| Collaborative Care Intervention (CCI) | Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 12 Months | 12 Months | Mild to Moderate Depression (0.5 - 1.7) | 121 Participants |
| Collaborative Care Intervention (CCI) | Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 12 Months | 12 Months | Severe Depression (> 1.7) | 63 Participants |
| Prevention Care Management (PCM) | Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 12 Months | 12 Months | Mild to Moderate Depression (0.5 - 1.7) | 141 Participants |
| Prevention Care Management (PCM) | Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 12 Months | Baseline | Mild to Moderate Depression (0.5 - 1.7) | 189 Participants |
| Prevention Care Management (PCM) | Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 12 Months | 12 Months | No Depression (<0.5) | 120 Participants |
| Prevention Care Management (PCM) | Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 12 Months | Baseline | No Depression (<0.5) | 43 Participants |
| Prevention Care Management (PCM) | Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 12 Months | 12 Months | Severe Depression (> 1.7) | 50 Participants |
| Prevention Care Management (PCM) | Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 12 Months | Baseline | Severe Depression (> 1.7) | 101 Participants |
Comparison: The Hopkins Symptom Checklist (SCL-20) at Baseline.p-value: 0.6Chi-squared
Comparison: The Hopkins Symptom Checklist (SCL-20) at 12 months.p-value: 0.23Chi-squared
Primary
Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 6 Months
The SCL-20 consists of the 20 depression items on a 4-point scale from the SCL-90, and has been shown to be a valid and reliable measure of depression in diverse outpatient and community populations.
Time frame: Baseline - 6 months
Population: This data is collected at baseline and 6 months. Not all participants completed all instruments at all time points.
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Collaborative Care Intervention (CCI) | Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 6 Months | Baseline | No Depression (<0.5) | 37 Participants |
| Collaborative Care Intervention (CCI) | Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 6 Months | Baseline | Severe Depression (> 1.7) | 92 Participants |
| Collaborative Care Intervention (CCI) | Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 6 Months | Baseline | Mild to Moderate Depression (0.5 - 1.7) | 198 Participants |
| Collaborative Care Intervention (CCI) | Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 6 Months | 6 month | No Depression (<0.5) | 100 Participants |
| Collaborative Care Intervention (CCI) | Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 6 Months | 6 month | Mild to Moderate Depression (0.5 - 1.7) | 137 Participants |
| Collaborative Care Intervention (CCI) | Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 6 Months | 6 month | Severe Depression (> 1.7) | 55 Participants |
| Prevention Care Management (PCM) | Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 6 Months | 6 month | Mild to Moderate Depression (0.5 - 1.7) | 147 Participants |
| Prevention Care Management (PCM) | Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 6 Months | Baseline | No Depression (<0.5) | 43 Participants |
| Prevention Care Management (PCM) | Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 6 Months | Baseline | Mild to Moderate Depression (0.5 - 1.7) | 189 Participants |
| Prevention Care Management (PCM) | Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 6 Months | 6 month | No Depression (<0.5) | 97 Participants |
| Prevention Care Management (PCM) | Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 6 Months | 6 month | Severe Depression (> 1.7) | 56 Participants |
| Prevention Care Management (PCM) | Change From Baseline in The Hopkins Symptom Checklist (SCL-20) at 6 Months | Baseline | Severe Depression (> 1.7) | 101 Participants |
Comparison: The Hopkins Symptom Checklist (SCL-20) at baseline.p-value: 0.6Chi-squared
Comparison: The Hopkins Symptom Checklist (SCL-20) at 6 Monthsp-value: 0.86Chi-squared
Primary
Changes From Baseline in Number of Participants With Colorectal, Breast, and/or Cervical Cancer Screening
Self-Report: We will ask participants about their participation (yes/no) in specific screening methods: Pap testing (past 3 years), mammography (past 2 years), and colorectal screening (fecal occult blood tests (FOBT)/fecal immunohistochemical tests (FIT)), past year; flexible sigmoidoscopy, the past 5 years; and colonoscopy, past 10 years).
Time frame: Baseline - 12 months
Population: This data is collected at baseline and 12 months. Not all participants completed all instruments at all time points.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Collaborative Care Intervention (CCI) | Changes From Baseline in Number of Participants With Colorectal, Breast, and/or Cervical Cancer Screening | Breast Cancer Screening - Baseline | 69.2 Percentage (%) of Participants |
| Collaborative Care Intervention (CCI) | Changes From Baseline in Number of Participants With Colorectal, Breast, and/or Cervical Cancer Screening | Colorectal Cancer Screening - Follow Up | 71.2 Percentage (%) of Participants |
| Collaborative Care Intervention (CCI) | Changes From Baseline in Number of Participants With Colorectal, Breast, and/or Cervical Cancer Screening | Colorectal Cancer Screening - Baseline | 42.9 Percentage (%) of Participants |
| Collaborative Care Intervention (CCI) | Changes From Baseline in Number of Participants With Colorectal, Breast, and/or Cervical Cancer Screening | Cervical Cancer Screening - Baseline | 83.3 Percentage (%) of Participants |
| Collaborative Care Intervention (CCI) | Changes From Baseline in Number of Participants With Colorectal, Breast, and/or Cervical Cancer Screening | Breast Cancer Screening - Follow Up | 89.9 Percentage (%) of Participants |
| Collaborative Care Intervention (CCI) | Changes From Baseline in Number of Participants With Colorectal, Breast, and/or Cervical Cancer Screening | Cervical Cancer Screening - Follow Up | 87.2 Percentage (%) of Participants |
| Prevention Care Management (PCM) | Changes From Baseline in Number of Participants With Colorectal, Breast, and/or Cervical Cancer Screening | Breast Cancer Screening - Follow Up | 87.6 Percentage (%) of Participants |
| Prevention Care Management (PCM) | Changes From Baseline in Number of Participants With Colorectal, Breast, and/or Cervical Cancer Screening | Colorectal Cancer Screening - Follow Up | 68.5 Percentage (%) of Participants |
| Prevention Care Management (PCM) | Changes From Baseline in Number of Participants With Colorectal, Breast, and/or Cervical Cancer Screening | Breast Cancer Screening - Baseline | 72.1 Percentage (%) of Participants |
| Prevention Care Management (PCM) | Changes From Baseline in Number of Participants With Colorectal, Breast, and/or Cervical Cancer Screening | Colorectal Cancer Screening - Baseline | 44.1 Percentage (%) of Participants |
| Prevention Care Management (PCM) | Changes From Baseline in Number of Participants With Colorectal, Breast, and/or Cervical Cancer Screening | Cervical Cancer Screening - Follow Up | 90.6 Percentage (%) of Participants |
| Prevention Care Management (PCM) | Changes From Baseline in Number of Participants With Colorectal, Breast, and/or Cervical Cancer Screening | Cervical Cancer Screening - Baseline | 82.2 Percentage (%) of Participants |
Comparison: Colorectal Cancer Screening Intervention Arm Difference at 12 Monthsp-value: 0.4483Chi-squared
Comparison: Cervical Cancer Screening Intervention Arm Difference at 12 Monthsp-value: 0.1706Chi-squared
Comparison: Breast Cancer Screening Intervention Arm Difference at 12 Monthsp-value: 0.3568Chi-squared
Primary
Comparison of Change in Patient Health Questionnaire-9 (PHQ9) Score by Intervention Arm
Comparison of change in depression between the CCI and PCM arm before and after intervention. (Self-Report). The Patient Health Questionnaire-9 (PHQ9) is a well-validated measure of Diagnostic and Statistical Manual of Mental Disorders 4th Edition (DSM-IV) criteria for screening and diagnosing depressive episode, assessing severity, and monitoring treatment response. The PHQ9 score ranges from the minimum of 0 (no depression) to the maximum of 27 (severe depression). The detailed PHQ9 scores and corresponding level of depression severity are as follow: 0 (no depression), 1-4 (mild depression), 5-9 (medium-mild depression), 10-14 (moderate depression), 15-19 (moderately severe depression) and 20-27 (severe depression). The mean change in PHQ9 score is the mean of the differences between PHQ9 score at baseline and the PHQ9 score at follow up for all cases in the respective intervention arm; the greater the change in PHQ9 score, the greater the improvement in depression severity.
Time frame: Baseline - 12 months
Population: These data are collected at baseline and 12 months. Not all participants completed all instruments at both time points.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Collaborative Care Intervention (CCI) | Comparison of Change in Patient Health Questionnaire-9 (PHQ9) Score by Intervention Arm | Mean PHQ9 Score at Baseline | 12.90 units on a scale | Standard Deviation 4.22 |
| Collaborative Care Intervention (CCI) | Comparison of Change in Patient Health Questionnaire-9 (PHQ9) Score by Intervention Arm | Mean Change in PHQ9 Score | 4.60 units on a scale | Standard Deviation 6.67 |
| Collaborative Care Intervention (CCI) | Comparison of Change in Patient Health Questionnaire-9 (PHQ9) Score by Intervention Arm | Mean PHQ9 Score at Follow Up | 8.24 units on a scale | Standard Deviation 6.67 |
| Prevention Care Management (PCM) | Comparison of Change in Patient Health Questionnaire-9 (PHQ9) Score by Intervention Arm | Mean PHQ9 Score at Baseline | 12.96 units on a scale | Standard Deviation 4.08 |
| Prevention Care Management (PCM) | Comparison of Change in Patient Health Questionnaire-9 (PHQ9) Score by Intervention Arm | Mean PHQ9 Score at Follow Up | 7.84 units on a scale | Standard Deviation 6.24 |
| Prevention Care Management (PCM) | Comparison of Change in Patient Health Questionnaire-9 (PHQ9) Score by Intervention Arm | Mean Change in PHQ9 Score | 5.05 units on a scale | Standard Deviation 6.44 |
Comparison: PHQ9 Intervention Arm Difference between baseline and 12-month follow upp-value: 0.39Two-sample t-test
Secondary
Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey
The Ambulatory Care Experiences Survey produces 11 summary measures covering 2 broad dimensions of patients' experiences: quality of physician-patient interactions and organizational features of care. The continuous summary score was converted into 4 categories (High, Moderate, Fair and Low) using quartiles as cut-points.
Time frame: Baseline, 6 months and 12 months
Population: This data is collected at baseline, 6 months and 12 months. Not all participants completed this instrument at all time points.
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Care Coordination - 6 Months | Moderate | 22 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Access - Baseline | Fair | 23 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Access - 6 Months | High | 26 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Access - Baseline | High | 24 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Access - 6 Months | Moderate | 0 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Care Coordination - 12 Months | Low | 250 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Access - 6 Months | Fair | 0 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Access - 12 Months | High | 28 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Access - 6 Months | Low | 287 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Access - 12 Months | Moderate | 0 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Shared Decision Making - 12 Months | Moderate | 0 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Access - 12 Months | Fair | 0 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Quality - 6 Months | Moderate | 0 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Access - 12 Months | Low | 288 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Care Coordination - Baseline | High | 67 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Quality - 6 Months | Fair | 0 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Care Coordination - Baseline | Low | 311 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Shared Decision Making - Baseline | High | 114 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Care Coordination - 6 Months | Fair | 23 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Shared Decision Making - 12 Months | High | 77 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Care Coordination - 6 Months | Low | 238 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Shared Decision Making - Baseline | Moderate | 0 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Care Coordination - 12 Months | High | 18 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Care Coordination - Baseline | Moderate | 0 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Care Coordination - 12 Months | Moderate | 9 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Shared Decision Making - Baseline | Fair | 0 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Care Coordination - 12 Months | Fair | 39 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Access - Baseline | Low | 306 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Quality - Baseline | High | 142 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Shared Decision Making - Baseline | Low | 264 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Quality - Baseline | Moderate | 0 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Shared Decision Making - 6 Months | Moderate | 0 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Quality - Baseline | Fair | 0 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Care Coordination - Baseline | Fair | 0 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Quality - Baseline | Low | 236 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Shared Decision Making - 6 Months | Fair | 0 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Quality - 6 Months | High | 121 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Care Coordination - 6 Months | High | 30 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Quality - 6 Months | Low | 192 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Shared Decision Making - 6 Months | Low | 232 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Quality - 12 Months | High | 116 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Shared Decision Making - 12 Months | Fair | 0 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Quality - 12 Months | Moderate | 0 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Shared Decision Making - 6 Months | High | 81 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Quality - 12 Months | Fair | 0 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Shared Decision Making - 12 Months | Low | 239 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Quality - 12 Months | Low | 200 Participants |
| Collaborative Care Intervention (CCI) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Access - Baseline | Moderate | 25 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Quality - 12 Months | Low | 211 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Shared Decision Making - 6 Months | High | 77 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Shared Decision Making - 6 Months | Low | 249 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Shared Decision Making - 12 Months | High | 108 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Shared Decision Making - 12 Months | Moderate | 0 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Shared Decision Making - 12 Months | Low | 225 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Access - Baseline | High | 23 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Access - Baseline | Fair | 27 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Access - Baseline | Low | 307 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Access - 6 Months | Fair | 0 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Access - 6 Months | Low | 296 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Care Coordination - Baseline | High | 61 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Care Coordination - Baseline | Moderate | 0 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Care Coordination - 6 Months | High | 19 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Care Coordination - 6 Months | Moderate | 22 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Care Coordination - 12 Months | Low | 272 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Quality - 6 Months | High | 115 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Quality - 6 Months | Moderate | 0 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Shared Decision Making - Baseline | High | 123 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Shared Decision Making - Baseline | Moderate | 0 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Shared Decision Making - Baseline | Fair | 0 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Shared Decision Making - 6 Months | Moderate | 0 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Shared Decision Making - 6 Months | Fair | 0 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Shared Decision Making - 12 Months | Fair | 0 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Access - Baseline | Moderate | 22 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Access - 6 Months | High | 30 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Access - 6 Months | Moderate | 0 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Access - 12 Months | High | 26 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Access - 12 Months | Moderate | 0 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Access - 12 Months | Fair | 0 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Access - 12 Months | Low | 307 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Care Coordination - Baseline | Fair | 0 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Care Coordination - Baseline | Low | 318 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Care Coordination - 6 Months | Fair | 27 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Care Coordination - 6 Months | Low | 258 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Care Coordination - 12 Months | High | 26 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Care Coordination - 12 Months | Moderate | 4 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Care Coordination - 12 Months | Fair | 31 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Quality - Baseline | High | 152 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Quality - Baseline | Moderate | 0 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Quality - Baseline | Fair | 0 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Quality - Baseline | Low | 227 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Quality - 6 Months | Fair | 0 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Quality - 6 Months | Low | 211 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Quality - 12 Months | High | 122 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Quality - 12 Months | Moderate | 0 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Quality - 12 Months | Fair | 0 Participants |
| Prevention Care Management (PCM) | Ambulatory Care Experiences as Assessed by Ambulatory Care Experiences Survey | Shared Decision Making - Baseline | Low | 256 Participants |
Comparison: Ambulatory Care Experiences - Shared Decision Making at baseline. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.5Chi-squared
Comparison: Ambulatory Care Experiences - Shared Decision Making at six months. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.51Chi-squared
Comparison: Ambulatory Care Experiences - Shared Decision Making at twelve months. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.02Chi-squared
Comparison: Ambulatory Care Experiences - Access at baseline. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.91Chi-squared
Comparison: Ambulatory Care Experiences - Access at six months. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.69Chi-squared
Comparison: Ambulatory Care Experiences - Access at twelve months. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.63Chi-squared
Comparison: Ambulatory Care Experiences - Care Coordination at baseline. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.55Chi-squared
Comparison: Ambulatory Care Experiences - Care Coordination at six months. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.34Chi-squared
Comparison: Ambulatory Care Experiences - Care Coordination at twelve months. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.19Chi-squared
Comparison: Ambulatory Care Experiences - Quality at baseline. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.47Chi-squared
Comparison: Ambulatory Care Experiences - Quality at six months. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.38Chi-squared
Comparison: Ambulatory Care Experiences - Quality at twelve months. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.98Chi-squared
Secondary
Breast, Cervical and Colorectal Cancer Screening Attitudes
This measure was adapted from the National Cancer Institute's HINTS questions for colorectal cancer. The continuous summary score was converted into 4 categories using quartiles as cut points. The categories for screening attitudes were as follows: positive attitudes, moderate attitudes, fair attitudes and negative attitudes.
Time frame: Baseline, 6 months and 12 months
Population: This data is collected at baseline, 6 months and 12 months. Not all participants completed the assessment at all time points.
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Colorectal Cancer Screening - Baseline | Negative Attitudes | 95 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Breast Cancer Screening - Baseline | Positive Attitudes | 71 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Cervical Cancer Screening - 12 months | Negative Attitudes | 129 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Breast Cancer Screening - Baseline | Moderate Attitudes | 62 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Colorectal Cancer Screening - 6 months | Positive Attitudes | 65 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Breast Cancer Screening - Baseline | Fair Attitudes | 136 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Cervical Cancer Screening - 12 months | Moderate Attitudes | 0 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Breast Cancer Screening - Baseline | Negative Attitudes | 108 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Colorectal Cancer Screening - 6 months | Moderate Attitudes | 46 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Breast Cancer Screening - 6 months | Positive Attitudes | 126 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Colorectal Cancer Screening - Baseline | Positive Attitudes | 71 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Breast Cancer Screening - 6 months | Moderate Attitudes | 0 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Breast Cancer Screening - 6 months | Fair Attitudes | 0 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Colorectal Cancer Screening - 6 months | Fair Attitudes | 83 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Breast Cancer Screening - 6 months | Negative Attitudes | 174 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Cervical Cancer Screening - 6 months | Positive Attitudes | 99 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Breast Cancer Screening - 12 months | Positive Attitudes | 131 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Colorectal Cancer Screening - 6 months | Negative Attitudes | 106 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Breast Cancer Screening - 12 months | Moderate Attitudes | 0 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Colorectal Cancer Screening - Baseline | Moderate Attitudes | 45 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Breast Cancer Screening - 12 months | Fair Attitudes | 0 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Colorectal Cancer Screening - 12 months | Positive Attitudes | 131 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Breast Cancer Screening - 12 months | Negative Attitudes | 177 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Cervical Cancer Screening - Baseline | Moderate Attitudes | 51 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Cervical Cancer Screening - 12 months | Fair Attitudes | 0 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Cervical Cancer Screening - Baseline | Fair Attitudes | 107 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Colorectal Cancer Screening - 12 months | Moderate Attitudes | 0 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Cervical Cancer Screening - Baseline | Negative Attitudes | 82 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Colorectal Cancer Screening - Baseline | Fair Attitudes | 161 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Cervical Cancer Screening - 6 months | Moderate Attitudes | 0 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Colorectal Cancer Screening - 12 months | Fair Attitudes | 0 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Cervical Cancer Screening - 6 months | Fair Attitudes | 0 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Cervical Cancer Screening - Baseline | Positive Attitudes | 60 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Cervical Cancer Screening - 6 months | Negative Attitudes | 124 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Colorectal Cancer Screening - 12 months | Negative Attitudes | 177 Participants |
| Collaborative Care Intervention (CCI) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Cervical Cancer Screening - 12 months | Positive Attitudes | 98 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Cervical Cancer Screening - Baseline | Fair Attitudes | 92 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Breast Cancer Screening - 12 months | Negative Attitudes | 183 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Cervical Cancer Screening - Baseline | Positive Attitudes | 64 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Cervical Cancer Screening - Baseline | Negative Attitudes | 81 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Cervical Cancer Screening - 12 months | Positive Attitudes | 108 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Cervical Cancer Screening - 12 months | Moderate Attitudes | 0 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Cervical Cancer Screening - 12 months | Fair Attitudes | 0 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Cervical Cancer Screening - 12 months | Negative Attitudes | 142 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Colorectal Cancer Screening - Baseline | Positive Attitudes | 71 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Colorectal Cancer Screening - Baseline | Moderate Attitudes | 55 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Colorectal Cancer Screening - Baseline | Fair Attitudes | 152 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Colorectal Cancer Screening - Baseline | Negative Attitudes | 95 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Colorectal Cancer Screening - 6 months | Positive Attitudes | 64 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Colorectal Cancer Screening - 6 months | Moderate Attitudes | 39 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Colorectal Cancer Screening - 6 months | Fair Attitudes | 86 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Colorectal Cancer Screening - 6 months | Negative Attitudes | 111 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Colorectal Cancer Screening - 12 months | Positive Attitudes | 134 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Colorectal Cancer Screening - 12 months | Moderate Attitudes | 0 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Colorectal Cancer Screening - 12 months | Fair Attitudes | 0 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Colorectal Cancer Screening - 12 months | Negative Attitudes | 189 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Breast Cancer Screening - Baseline | Positive Attitudes | 79 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Breast Cancer Screening - Baseline | Moderate Attitudes | 61 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Breast Cancer Screening - Baseline | Fair Attitudes | 132 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Breast Cancer Screening - Baseline | Negative Attitudes | 105 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Breast Cancer Screening - 6 months | Positive Attitudes | 124 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Breast Cancer Screening - 6 months | Fair Attitudes | 0 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Breast Cancer Screening - 6 months | Negative Attitudes | 182 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Breast Cancer Screening - 12 months | Positive Attitudes | 142 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Breast Cancer Screening - 12 months | Moderate Attitudes | 0 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Breast Cancer Screening - 12 months | Fair Attitudes | 0 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Cervical Cancer Screening - Baseline | Moderate Attitudes | 58 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Breast Cancer Screening - 6 months | Moderate Attitudes | 0 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Cervical Cancer Screening - 6 months | Positive Attitudes | 85 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Cervical Cancer Screening - 6 months | Moderate Attitudes | 0 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Cervical Cancer Screening - 6 months | Fair Attitudes | 0 Participants |
| Prevention Care Management (PCM) | Breast, Cervical and Colorectal Cancer Screening Attitudes | Cervical Cancer Screening - 6 months | Negative Attitudes | 145 Participants |
Comparison: Colorectal Cancer Screening attitudes at baseline. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.74Chi-squared
Comparison: Colorectal Cancer Screening attitudes at 6 months. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.86Chi-squared
Comparison: Colorectal Cancer Screening attitudes at 12 months. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.79Chi-squared
Comparison: Breast Cancer Screening attitudes at baseline. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.91Chi-squared
Comparison: Breast Cancer Screening attitudes at 6 months. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.71Chi-squared
Comparison: Breast Cancer Screening attitudes at 12 months. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.77Chi-squared
Comparison: Cervical Cancer Screening attitudes at baseline. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.64Chi-squared
Comparison: Cervical Cancer Screening attitudes at 6 months. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.11Chi-squared
Comparison: Cervical Cancer Screening attitudes at 12 months. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 1Chi-squared
Secondary
Devaluation-Discrimination Scale
This measure was adapted from the Link's Devaluation-Discrimination Scale.The continuous summary score was converted into 4 categories using quartiles as cut points. The 4 categories were as follows: Low stigma, minimal stigma, moderate stigma and high stigma.
Time frame: Baseline and 12 months
Population: This data is collected at baseline and 12 months. Not all participants completed this instrument at all time points.
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Collaborative Care Intervention (CCI) | Devaluation-Discrimination Scale | Baseline | Low Stigma | 68 Participants |
| Collaborative Care Intervention (CCI) | Devaluation-Discrimination Scale | 12 months | Minimal Stigma | 36 Participants |
| Collaborative Care Intervention (CCI) | Devaluation-Discrimination Scale | Baseline | Minimal Stigma | 42 Participants |
| Collaborative Care Intervention (CCI) | Devaluation-Discrimination Scale | Baseline | Moderate Stigma | 46 Participants |
| Collaborative Care Intervention (CCI) | Devaluation-Discrimination Scale | Baseline | High Stigma | 36 Participants |
| Collaborative Care Intervention (CCI) | Devaluation-Discrimination Scale | 12 months | Low Stigma | 50 Participants |
| Collaborative Care Intervention (CCI) | Devaluation-Discrimination Scale | 12 months | Moderate Stigma | 30 Participants |
| Collaborative Care Intervention (CCI) | Devaluation-Discrimination Scale | 12 months | High Stigma | 44 Participants |
| Prevention Care Management (PCM) | Devaluation-Discrimination Scale | Baseline | Moderate Stigma | 49 Participants |
| Prevention Care Management (PCM) | Devaluation-Discrimination Scale | 12 months | Low Stigma | 55 Participants |
| Prevention Care Management (PCM) | Devaluation-Discrimination Scale | 12 months | Minimal Stigma | 48 Participants |
| Prevention Care Management (PCM) | Devaluation-Discrimination Scale | 12 months | High Stigma | 34 Participants |
| Prevention Care Management (PCM) | Devaluation-Discrimination Scale | Baseline | Low Stigma | 50 Participants |
| Prevention Care Management (PCM) | Devaluation-Discrimination Scale | Baseline | High Stigma | 49 Participants |
| Prevention Care Management (PCM) | Devaluation-Discrimination Scale | Baseline | Minimal Stigma | 45 Participants |
| Prevention Care Management (PCM) | Devaluation-Discrimination Scale | 12 months | Moderate Stigma | 26 Participants |
Comparison: Devaluation-Discrimination Scale Score at baseline. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.18Chi-squared
Comparison: Devaluation-Discrimination Scale score at 12 months. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.32Chi-squared
Secondary
Generalized Anxiety Disorder
This Generalized Anxiety Disorder scale is based on diagnostic criteria in the Diagnostic and Statistical Manual of Mental Disorders 4th Edition (DSM-IV) and measures probable anxiety disorder and severity of anxiety symptoms. Patients are asked to rate how often they have been bothered by 7 problems in the last 2 weeks on a 4-point scale. Standard cut points were used for the Generalized Anxiety Disorder measure. Minimal anxiety is (0-4). Mild Anxiety would be count as (5-9). Moderate Anxiety (10-14) and severe anxiety would be (15-21).
Time frame: Baseline, 6 months and 12 months
Population: This data is collected at baseline, 6 months and 12 months. Not all participants completed the assessment at all time points.
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Collaborative Care Intervention (CCI) | Generalized Anxiety Disorder | 6 months | Severe Anxiety (15-21) | 37 Participants |
| Collaborative Care Intervention (CCI) | Generalized Anxiety Disorder | 6 months | Mild Anxiety (5-9) | 69 Participants |
| Collaborative Care Intervention (CCI) | Generalized Anxiety Disorder | Baseline | Mild Anxiety (5-9) | 114 Participants |
| Collaborative Care Intervention (CCI) | Generalized Anxiety Disorder | 6 months | Moderate Anxiety (10-14) | 61 Participants |
| Collaborative Care Intervention (CCI) | Generalized Anxiety Disorder | Baseline | Moderate Anxiety (10-14) | 89 Participants |
| Collaborative Care Intervention (CCI) | Generalized Anxiety Disorder | 12 months | Severe Anxiety (15-21) | 56 Participants |
| Collaborative Care Intervention (CCI) | Generalized Anxiety Disorder | 12 months | Minimal Anxiety (0-4) | 124 Participants |
| Collaborative Care Intervention (CCI) | Generalized Anxiety Disorder | Baseline | Minimal Anxiety (0-4) | 79 Participants |
| Collaborative Care Intervention (CCI) | Generalized Anxiety Disorder | 12 months | Mild Anxiety (5-9) | 82 Participants |
| Collaborative Care Intervention (CCI) | Generalized Anxiety Disorder | 6 months | Minimal Anxiety (0-4) | 133 Participants |
| Collaborative Care Intervention (CCI) | Generalized Anxiety Disorder | 12 months | Moderate Anxiety (10-14) | 46 Participants |
| Collaborative Care Intervention (CCI) | Generalized Anxiety Disorder | Baseline | Severe Anxiety (15-21) | 90 Participants |
| Prevention Care Management (PCM) | Generalized Anxiety Disorder | 12 months | Moderate Anxiety (10-14) | 56 Participants |
| Prevention Care Management (PCM) | Generalized Anxiety Disorder | 12 months | Severe Anxiety (15-21) | 44 Participants |
| Prevention Care Management (PCM) | Generalized Anxiety Disorder | Baseline | Mild Anxiety (5-9) | 108 Participants |
| Prevention Care Management (PCM) | Generalized Anxiety Disorder | Baseline | Minimal Anxiety (0-4) | 79 Participants |
| Prevention Care Management (PCM) | Generalized Anxiety Disorder | Baseline | Moderate Anxiety (10-14) | 95 Participants |
| Prevention Care Management (PCM) | Generalized Anxiety Disorder | Baseline | Severe Anxiety (15-21) | 90 Participants |
| Prevention Care Management (PCM) | Generalized Anxiety Disorder | 6 months | Minimal Anxiety (0-4) | 127 Participants |
| Prevention Care Management (PCM) | Generalized Anxiety Disorder | 6 months | Mild Anxiety (5-9) | 82 Participants |
| Prevention Care Management (PCM) | Generalized Anxiety Disorder | 6 months | Moderate Anxiety (10-14) | 42 Participants |
| Prevention Care Management (PCM) | Generalized Anxiety Disorder | 6 months | Severe Anxiety (15-21) | 50 Participants |
| Prevention Care Management (PCM) | Generalized Anxiety Disorder | 12 months | Minimal Anxiety (0-4) | 145 Participants |
| Prevention Care Management (PCM) | Generalized Anxiety Disorder | 12 months | Mild Anxiety (5-9) | 77 Participants |
Comparison: Generalized Anxiety Disorder scale at baseline. Coding of the measure was based on Spitzer, R.L., Kroenke, K., Williams, J.B., \& Lowe, B. (2006).p-value: 0.95Chi-squared
Comparison: Generalized Anxiety Disorder scale score at 6 months. Coding of the measure was based on Spitzer, R.L., Kroenke, K., Williams, J.B., \& Lowe, B. (2006).p-value: 0.08Chi-squared
Comparison: Generalized Anxiety Disorder scale score at 12 months. Coding of the measure was based on Spitzer, R.L., Kroenke, K., Williams, J.B., \& Lowe, B. (2006).p-value: 0.27Chi-squared
Secondary
Medical Outcomes Study Health Survey-Short Form
The quality of life was measured with the Medical Outcomes Study (MOS) Short Form Health Survey (SF-12) is a general measure of health status that assess the patient's perceived health status and whether health problems interfere with normal functioning. The SF-12 has demonstrated validity and test-retest reliability in the general population and in patients with chronic health conditions, and has been tested in five languages, including Spanish. It has been used extensively as a quality of life measure in collaborative care studies, including with low-income minority populations. It has also been used frequently in screening studies, for cancer and other conditions. The SF-12 has been validated as an indicator of effects of depression on quality of life in ethnically diverse patients. The continuous summary score was converted into 4 categories using quartiles as cutoff points. The four categories are Best Health, Good health, Fair Health and Worst Health.
Time frame: Baseline, 6 months and 12 months
Population: This data is collected at baseline, 6 months and 12 months. Not all participants completed the assessment at all time points.
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Collaborative Care Intervention (CCI) | Medical Outcomes Study Health Survey-Short Form | Baseline | Fair Health | 92 Participants |
| Collaborative Care Intervention (CCI) | Medical Outcomes Study Health Survey-Short Form | Baseline | Worst Health | 96 Participants |
| Collaborative Care Intervention (CCI) | Medical Outcomes Study Health Survey-Short Form | 12 months | Best Health | 73 Participants |
| Collaborative Care Intervention (CCI) | Medical Outcomes Study Health Survey-Short Form | 6 months | Good Health | 77 Participants |
| Collaborative Care Intervention (CCI) | Medical Outcomes Study Health Survey-Short Form | 6 months | Fair Health | 65 Participants |
| Collaborative Care Intervention (CCI) | Medical Outcomes Study Health Survey-Short Form | 6 months | Worst Health | 81 Participants |
| Collaborative Care Intervention (CCI) | Medical Outcomes Study Health Survey-Short Form | Baseline | Good Health | 86 Participants |
| Collaborative Care Intervention (CCI) | Medical Outcomes Study Health Survey-Short Form | 12 months | Good Health | 79 Participants |
| Collaborative Care Intervention (CCI) | Medical Outcomes Study Health Survey-Short Form | 12 months | Fair Health | 72 Participants |
| Collaborative Care Intervention (CCI) | Medical Outcomes Study Health Survey-Short Form | 6 months | Best Health | 70 Participants |
| Collaborative Care Intervention (CCI) | Medical Outcomes Study Health Survey-Short Form | 12 months | Worst Health | 83 Participants |
| Collaborative Care Intervention (CCI) | Medical Outcomes Study Health Survey-Short Form | Baseline | Best Health | 96 Participants |
| Prevention Care Management (PCM) | Medical Outcomes Study Health Survey-Short Form | 12 months | Worst Health | 76 Participants |
| Prevention Care Management (PCM) | Medical Outcomes Study Health Survey-Short Form | Baseline | Best Health | 88 Participants |
| Prevention Care Management (PCM) | Medical Outcomes Study Health Survey-Short Form | 6 months | Best Health | 74 Participants |
| Prevention Care Management (PCM) | Medical Outcomes Study Health Survey-Short Form | 6 months | Fair Health | 75 Participants |
| Prevention Care Management (PCM) | Medical Outcomes Study Health Survey-Short Form | 6 months | Worst Health | 71 Participants |
| Prevention Care Management (PCM) | Medical Outcomes Study Health Survey-Short Form | 12 months | Good Health | 77 Participants |
| Prevention Care Management (PCM) | Medical Outcomes Study Health Survey-Short Form | Baseline | Good Health | 95 Participants |
| Prevention Care Management (PCM) | Medical Outcomes Study Health Survey-Short Form | Baseline | Fair Health | 96 Participants |
| Prevention Care Management (PCM) | Medical Outcomes Study Health Survey-Short Form | Baseline | Worst Health | 80 Participants |
| Prevention Care Management (PCM) | Medical Outcomes Study Health Survey-Short Form | 6 months | Good Health | 82 Participants |
| Prevention Care Management (PCM) | Medical Outcomes Study Health Survey-Short Form | 12 months | Best Health | 83 Participants |
| Prevention Care Management (PCM) | Medical Outcomes Study Health Survey-Short Form | 12 months | Fair Health | 83 Participants |
Comparison: Medical Outcomes Study Health Survey at baseline. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.54Chi-squared
Comparison: Medical Outcomes Study Health Survey at 6 months. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.68Chi-squared
Comparison: Medical Outcomes Study Health Survey at 12 months. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.68Chi-squared
Secondary
Medication Adherence
In this questionnaire, respondents were asked if they had been prescribed medication for depression and about difficulties taking medication(s) regularly. Standard cut points was used for medical adherence. High adherence- around an 8. Medium adherence - 6-7.99. Low adherence would be anything less than 6.
Time frame: Baseline, 6 months and 12 months
Population: This data is collected at baseline, 6 months and 12 months. Not all participants completed the assessment at all time points
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Collaborative Care Intervention (CCI) | Medication Adherence | Baseline | Low Adherence (<6) | 75 Participants |
| Collaborative Care Intervention (CCI) | Medication Adherence | 12 months | Medium Adherence (6-7.99) | 33 Participants |
| Collaborative Care Intervention (CCI) | Medication Adherence | 6 months | Low Adherence (<6) | 60 Participants |
| Collaborative Care Intervention (CCI) | Medication Adherence | Baseline | High Adherence (8) | 20 Participants |
| Collaborative Care Intervention (CCI) | Medication Adherence | 6 months | High Adherence (8) | 20 Participants |
| Collaborative Care Intervention (CCI) | Medication Adherence | 12 months | High Adherence (8) | 22 Participants |
| Collaborative Care Intervention (CCI) | Medication Adherence | 6 months | Medium Adherence (6-7.99) | 35 Participants |
| Collaborative Care Intervention (CCI) | Medication Adherence | 12 months | Low Adherence (<6) | 60 Participants |
| Collaborative Care Intervention (CCI) | Medication Adherence | Baseline | Medium Adherence (6-7.99) | 30 Participants |
| Prevention Care Management (PCM) | Medication Adherence | 12 months | Low Adherence (<6) | 61 Participants |
| Prevention Care Management (PCM) | Medication Adherence | Baseline | Medium Adherence (6-7.99) | 32 Participants |
| Prevention Care Management (PCM) | Medication Adherence | Baseline | Low Adherence (<6) | 74 Participants |
| Prevention Care Management (PCM) | Medication Adherence | 6 months | Medium Adherence (6-7.99) | 23 Participants |
| Prevention Care Management (PCM) | Medication Adherence | 6 months | Low Adherence (<6) | 68 Participants |
| Prevention Care Management (PCM) | Medication Adherence | 12 months | High Adherence (8) | 27 Participants |
| Prevention Care Management (PCM) | Medication Adherence | 12 months | Medium Adherence (6-7.99) | 31 Participants |
| Prevention Care Management (PCM) | Medication Adherence | Baseline | High Adherence (8) | 25 Participants |
| Prevention Care Management (PCM) | Medication Adherence | 6 months | High Adherence (8) | 23 Participants |
Comparison: Medication Adherence at baseline. Coding of the measure was based on Morisky et al. (2008).p-value: 0.78Chi-squared
Comparison: Medication Adherence at 6 months. Coding of the measure was based on Morisky et al. (2008).p-value: 0.2Chi-squared
Comparison: Medication Adherence at 12 Months. Coding of the measure was based on Morisky et al. (2008).p-value: 0.77Chi-squared
Secondary
Mental Health Care Utilization: Assessed by Patient Report
Participants were asked how many times in the past six months they had seen a provider to talk about or to receive medication for feeling sad, nervous, hopeless, or blue. This question was adapted from the NCI's HINTS survey. Two categories were created using the median as a cut point. The two categories were high utilization and low utilization.
Time frame: Baseline, 6 months and 12 months
Population: This data is collected at baseline, 6 months and 12 months for 3 different instruments. Not all participants completed all instruments at all time points.
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Collaborative Care Intervention (CCI) | Mental Health Care Utilization: Assessed by Patient Report | Mental Health Visits - Baseline | Low Utilization | 216 Participants |
| Collaborative Care Intervention (CCI) | Mental Health Care Utilization: Assessed by Patient Report | Mental Health Visits - 6 Months | High Utilization | 116 Participants |
| Collaborative Care Intervention (CCI) | Mental Health Care Utilization: Assessed by Patient Report | Mental Health Prescriptions - Baseline | Low Utilization | 241 Participants |
| Collaborative Care Intervention (CCI) | Mental Health Care Utilization: Assessed by Patient Report | Mental Health Visits - 6 Months | Low Utilization | 197 Participants |
| Collaborative Care Intervention (CCI) | Mental Health Care Utilization: Assessed by Patient Report | Mental Health Prescriptions - Baseline | High Utilization | 137 Participants |
| Collaborative Care Intervention (CCI) | Mental Health Care Utilization: Assessed by Patient Report | Mental Health Visits - 12 Months | High Utilization | 125 Participants |
| Collaborative Care Intervention (CCI) | Mental Health Care Utilization: Assessed by Patient Report | Mental Health Visits - 12 Months | Low Utilization | 191 Participants |
| Collaborative Care Intervention (CCI) | Mental Health Care Utilization: Assessed by Patient Report | Mental Health Prescriptions - 6 Months | High Utilization | 126 Participants |
| Collaborative Care Intervention (CCI) | Mental Health Care Utilization: Assessed by Patient Report | Mental Health Prescriptions - 12 Months | High Utilization | 128 Participants |
| Collaborative Care Intervention (CCI) | Mental Health Care Utilization: Assessed by Patient Report | Mental Health Prescriptions - 6 Months | Low Utilization | 187 Participants |
| Collaborative Care Intervention (CCI) | Mental Health Care Utilization: Assessed by Patient Report | Mental Health Prescriptions - 12 Months | Low Utilization | 188 Participants |
| Collaborative Care Intervention (CCI) | Mental Health Care Utilization: Assessed by Patient Report | Mental Health Visits - Baseline | High Utilization | 162 Participants |
| Prevention Care Management (PCM) | Mental Health Care Utilization: Assessed by Patient Report | Mental Health Prescriptions - 12 Months | Low Utilization | 198 Participants |
| Prevention Care Management (PCM) | Mental Health Care Utilization: Assessed by Patient Report | Mental Health Visits - Baseline | High Utilization | 165 Participants |
| Prevention Care Management (PCM) | Mental Health Care Utilization: Assessed by Patient Report | Mental Health Visits - Baseline | Low Utilization | 214 Participants |
| Prevention Care Management (PCM) | Mental Health Care Utilization: Assessed by Patient Report | Mental Health Visits - 12 Months | High Utilization | 132 Participants |
| Prevention Care Management (PCM) | Mental Health Care Utilization: Assessed by Patient Report | Mental Health Visits - 12 Months | Low Utilization | 201 Participants |
| Prevention Care Management (PCM) | Mental Health Care Utilization: Assessed by Patient Report | Mental Health Prescriptions - Baseline | High Utilization | 145 Participants |
| Prevention Care Management (PCM) | Mental Health Care Utilization: Assessed by Patient Report | Mental Health Prescriptions - Baseline | Low Utilization | 234 Participants |
| Prevention Care Management (PCM) | Mental Health Care Utilization: Assessed by Patient Report | Mental Health Prescriptions - 6 Months | Low Utilization | 196 Participants |
| Prevention Care Management (PCM) | Mental Health Care Utilization: Assessed by Patient Report | Mental Health Visits - 6 Months | High Utilization | 136 Participants |
| Prevention Care Management (PCM) | Mental Health Care Utilization: Assessed by Patient Report | Mental Health Visits - 6 Months | Low Utilization | 190 Participants |
| Prevention Care Management (PCM) | Mental Health Care Utilization: Assessed by Patient Report | Mental Health Prescriptions - 6 Months | High Utilization | 130 Participants |
| Prevention Care Management (PCM) | Mental Health Care Utilization: Assessed by Patient Report | Mental Health Prescriptions - 12 Months | High Utilization | 135 Participants |
Comparison: Mental Health Care Utilization - Mental Health Visits at baseline.p-value: 0.85Chi-squared
Comparison: Mental Health Care Utilization - Mental Health Visits at 6 months.p-value: 0.23Chi-squared
Comparison: Mental Health Care Utilization - Mental Health Visits at 12 months.p-value: 0.98Chi-squared
Comparison: Mental Health Care Utilization - Mental Health Prescriptions at baseline.p-value: 0.57Chi-squared
Comparison: Mental Health Care Utilization - Mental Health Prescriptions at 6 months.p-value: 0.92Chi-squared
Comparison: Mental Health Care Utilization - Mental Health Prescriptions at 12 months.p-value: 0.99Chi-squared
Secondary
Physician Recommendation of Screening/Mental Health Care
This questionnaire, adopted from National Cancer Institute's (NCI) Health Information National Trends Survey (HINTS), assesses whether patients report that their primary care physician 1) has recommended cervical, breast, and colon cancer screening and 2) has recommended that the patient make an appointment with a mental health provider and/or take psychotropic medication. Two categories were created according to whether the patient received a physician recommendation (yes/no). The category of Recommendation for when they received a recommendation and a category of No Recommendation if they did not receive a recommendation
Time frame: Baseline, 6 months and 12 months
Population: Data are collected at baseline, 6 months and 12 months. Not all participants completed the assessment at all time points.
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Collaborative Care Intervention (CCI) | Physician Recommendation of Screening/Mental Health Care | Colorectal Cancer Screening - Baseline | No Recommendation | 80 Participants |
| Collaborative Care Intervention (CCI) | Physician Recommendation of Screening/Mental Health Care | Colorectal Cancer Screening - 6 Months | No Recommendation | 23 Participants |
| Collaborative Care Intervention (CCI) | Physician Recommendation of Screening/Mental Health Care | Colorectal Cancer Screening - 12 Months | No Recommendation | 31 Participants |
| Collaborative Care Intervention (CCI) | Physician Recommendation of Screening/Mental Health Care | Breast Cancer Screening - Baseline | No Recommendation | 37 Participants |
| Collaborative Care Intervention (CCI) | Physician Recommendation of Screening/Mental Health Care | Cervical Cancer Screening - 6 Months | Recommendation | 281 Participants |
| Collaborative Care Intervention (CCI) | Physician Recommendation of Screening/Mental Health Care | Breast Cancer Screening - 6 Months | Recommendation | 299 Participants |
| Collaborative Care Intervention (CCI) | Physician Recommendation of Screening/Mental Health Care | Colorectal Cancer Screening - Baseline | Recommendation | 298 Participants |
| Collaborative Care Intervention (CCI) | Physician Recommendation of Screening/Mental Health Care | Breast Cancer Screening - 6 Months | No Recommendation | 5 Participants |
| Collaborative Care Intervention (CCI) | Physician Recommendation of Screening/Mental Health Care | Cervical Cancer Screening - 12 Months | Recommendation | 279 Participants |
| Collaborative Care Intervention (CCI) | Physician Recommendation of Screening/Mental Health Care | Breast Cancer Screening - 12 Months | Recommendation | 302 Participants |
| Collaborative Care Intervention (CCI) | Physician Recommendation of Screening/Mental Health Care | Breast Cancer Screening - 12 Months | No Recommendation | 10 Participants |
| Collaborative Care Intervention (CCI) | Physician Recommendation of Screening/Mental Health Care | Colorectal Cancer Screening - 12 Months | Recommendation | 281 Participants |
| Collaborative Care Intervention (CCI) | Physician Recommendation of Screening/Mental Health Care | Cervical Cancer Screening - Baseline | Recommendation | 309 Participants |
| Collaborative Care Intervention (CCI) | Physician Recommendation of Screening/Mental Health Care | Colorectal Cancer Screening - 6 Months | Recommendation | 281 Participants |
| Collaborative Care Intervention (CCI) | Physician Recommendation of Screening/Mental Health Care | Cervical Cancer Screening - Baseline | No Recommendation | 69 Participants |
| Collaborative Care Intervention (CCI) | Physician Recommendation of Screening/Mental Health Care | Mental Health Care - Baseline | Recommendation | 206 Participants |
| Collaborative Care Intervention (CCI) | Physician Recommendation of Screening/Mental Health Care | Cervical Cancer Screening - 6 Months | No Recommendation | 23 Participants |
| Collaborative Care Intervention (CCI) | Physician Recommendation of Screening/Mental Health Care | Mental Health Care - Baseline | No Recommendation | 172 Participants |
| Collaborative Care Intervention (CCI) | Physician Recommendation of Screening/Mental Health Care | Cervical Cancer Screening - 12 Months | No Recommendation | 33 Participants |
| Collaborative Care Intervention (CCI) | Physician Recommendation of Screening/Mental Health Care | Mental Health Care - 6 Months | No Recommendation | 121 Participants |
| Collaborative Care Intervention (CCI) | Physician Recommendation of Screening/Mental Health Care | Mental Health Care - 6 Months | Recommendation | 183 Participants |
| Collaborative Care Intervention (CCI) | Physician Recommendation of Screening/Mental Health Care | Breast Cancer Screening - Baseline | Recommendation | 340 Participants |
| Collaborative Care Intervention (CCI) | Physician Recommendation of Screening/Mental Health Care | Mental Health Care - 12 Months | Recommendation | 182 Participants |
| Collaborative Care Intervention (CCI) | Physician Recommendation of Screening/Mental Health Care | Mental Health Care - 12 Months | No Recommendation | 130 Participants |
| Prevention Care Management (PCM) | Physician Recommendation of Screening/Mental Health Care | Cervical Cancer Screening - 6 Months | No Recommendation | 31 Participants |
| Prevention Care Management (PCM) | Physician Recommendation of Screening/Mental Health Care | Colorectal Cancer Screening - Baseline | Recommendation | 282 Participants |
| Prevention Care Management (PCM) | Physician Recommendation of Screening/Mental Health Care | Colorectal Cancer Screening - Baseline | No Recommendation | 96 Participants |
| Prevention Care Management (PCM) | Physician Recommendation of Screening/Mental Health Care | Colorectal Cancer Screening - 6 Months | Recommendation | 284 Participants |
| Prevention Care Management (PCM) | Physician Recommendation of Screening/Mental Health Care | Colorectal Cancer Screening - 6 Months | No Recommendation | 30 Participants |
| Prevention Care Management (PCM) | Physician Recommendation of Screening/Mental Health Care | Colorectal Cancer Screening - 12 Months | No Recommendation | 20 Participants |
| Prevention Care Management (PCM) | Physician Recommendation of Screening/Mental Health Care | Breast Cancer Screening - Baseline | Recommendation | 339 Participants |
| Prevention Care Management (PCM) | Physician Recommendation of Screening/Mental Health Care | Breast Cancer Screening - 12 Months | Recommendation | 321 Participants |
| Prevention Care Management (PCM) | Physician Recommendation of Screening/Mental Health Care | Cervical Cancer Screening - 6 Months | Recommendation | 283 Participants |
| Prevention Care Management (PCM) | Physician Recommendation of Screening/Mental Health Care | Cervical Cancer Screening - 12 Months | Recommendation | 299 Participants |
| Prevention Care Management (PCM) | Physician Recommendation of Screening/Mental Health Care | Cervical Cancer Screening - 12 Months | No Recommendation | 28 Participants |
| Prevention Care Management (PCM) | Physician Recommendation of Screening/Mental Health Care | Mental Health Care - 6 Months | No Recommendation | 122 Participants |
| Prevention Care Management (PCM) | Physician Recommendation of Screening/Mental Health Care | Mental Health Care - 12 Months | No Recommendation | 125 Participants |
| Prevention Care Management (PCM) | Physician Recommendation of Screening/Mental Health Care | Colorectal Cancer Screening - 12 Months | Recommendation | 308 Participants |
| Prevention Care Management (PCM) | Physician Recommendation of Screening/Mental Health Care | Breast Cancer Screening - Baseline | No Recommendation | 37 Participants |
| Prevention Care Management (PCM) | Physician Recommendation of Screening/Mental Health Care | Breast Cancer Screening - 6 Months | Recommendation | 303 Participants |
| Prevention Care Management (PCM) | Physician Recommendation of Screening/Mental Health Care | Breast Cancer Screening - 6 Months | No Recommendation | 11 Participants |
| Prevention Care Management (PCM) | Physician Recommendation of Screening/Mental Health Care | Breast Cancer Screening - 12 Months | No Recommendation | 8 Participants |
| Prevention Care Management (PCM) | Physician Recommendation of Screening/Mental Health Care | Cervical Cancer Screening - Baseline | Recommendation | 297 Participants |
| Prevention Care Management (PCM) | Physician Recommendation of Screening/Mental Health Care | Cervical Cancer Screening - Baseline | No Recommendation | 79 Participants |
| Prevention Care Management (PCM) | Physician Recommendation of Screening/Mental Health Care | Mental Health Care - Baseline | Recommendation | 206 Participants |
| Prevention Care Management (PCM) | Physician Recommendation of Screening/Mental Health Care | Mental Health Care - Baseline | No Recommendation | 168 Participants |
| Prevention Care Management (PCM) | Physician Recommendation of Screening/Mental Health Care | Mental Health Care - 6 Months | Recommendation | 191 Participants |
| Prevention Care Management (PCM) | Physician Recommendation of Screening/Mental Health Care | Mental Health Care - 12 Months | Recommendation | 203 Participants |
Comparison: Physician Recommendation of Colorectal Cancer Screening at baseline.p-value: 0.17Chi-squared
Comparison: Physician Recommendation of Colorectal Cancer Screening at 6 months.p-value: 0.38Chi-squared
Comparison: Physician Recommendation of Colorectal Cancer Screening at 12 months.p-value: 0.07Chi-squared
Comparison: Physician Recommendation of Breast Cancer Screening at baseline.p-value: 0.99Chi-squared
Comparison: Physician Recommendation of Breast Cancer Screening at 6 months.p-value: 0.15Chi-squared
Comparison: Physician Recommendation of Breast Cancer Screening at 12 months.p-value: 0.55Chi-squared
Comparison: Physician Recommendation of Cervical Cancer Screening at baseline.p-value: 0.34Chi-squared
Comparison: Physician Recommendation of Cervical Cancer Screening at 6 months. .p-value: 0.31Chi-squared
Comparison: Physician Recommendation of Cervical Cancer Screening at 12 months.p-value: 0.39Chi-squared
Comparison: Physician Recommendation of Mental Health Care at baseline.p-value: 0.87Chi-squared
Comparison: Physician Recommendation of Mental Health Care at 6 months.p-value: 0.83Chi-squared
Comparison: Physician Recommendation of Mental Health Care at 12 months.p-value: 0.36Chi-squared
Secondary
Satisfaction With Decision Scale- Cancer Screening (Data Reported in Outcome Measure #10)
The Satisfaction with Decision Scale is a 6-item measure that uses a five-point Likert-type scale; it is grounded in a conceptual model of an effective decision, i.e., one that is informed, consistent with the decision-maker's values, and behaviorally implemented. This scale has been tailored to healthcare decisions to have cervical, breast, and colon cancer screening.The satisfaction with decision scale of cancer screening and its continuous summary score was converted into two categories (high satisfaction and low satisfaction) using the median as the cutoff point.
Time frame: Baseline, 6 months and 12 months
Population: This data is collected at baseline, 6 months and 12 months. Not all participants completed the assessment at all time points.
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Collaborative Care Intervention (CCI) | Satisfaction With Decision Scale- Cancer Screening (Data Reported in Outcome Measure #10) | Colorectal Cancer Screening - Baseline | High Satisfaction | 161 Participants |
| Collaborative Care Intervention (CCI) | Satisfaction With Decision Scale- Cancer Screening (Data Reported in Outcome Measure #10) | Colorectal Cancer Screening - 12 Months | High Satisfaction | 135 Participants |
| Collaborative Care Intervention (CCI) | Satisfaction With Decision Scale- Cancer Screening (Data Reported in Outcome Measure #10) | Colorectal Cancer Screening - Baseline | Low Satisfaction | 212 Participants |
| Collaborative Care Intervention (CCI) | Satisfaction With Decision Scale- Cancer Screening (Data Reported in Outcome Measure #10) | Colorectal Cancer Screening - 6 months | High Satisfaction | 112 Participants |
| Collaborative Care Intervention (CCI) | Satisfaction With Decision Scale- Cancer Screening (Data Reported in Outcome Measure #10) | Colorectal Cancer Screening - 6 months | Low Satisfaction | 183 Participants |
| Collaborative Care Intervention (CCI) | Satisfaction With Decision Scale- Cancer Screening (Data Reported in Outcome Measure #10) | Colorectal Cancer Screening - 12 Months | Low Satisfaction | 170 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision Scale- Cancer Screening (Data Reported in Outcome Measure #10) | Colorectal Cancer Screening - 6 months | Low Satisfaction | 170 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision Scale- Cancer Screening (Data Reported in Outcome Measure #10) | Colorectal Cancer Screening - Baseline | High Satisfaction | 180 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision Scale- Cancer Screening (Data Reported in Outcome Measure #10) | Colorectal Cancer Screening - 6 months | High Satisfaction | 131 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision Scale- Cancer Screening (Data Reported in Outcome Measure #10) | Colorectal Cancer Screening - 12 Months | High Satisfaction | 148 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision Scale- Cancer Screening (Data Reported in Outcome Measure #10) | Colorectal Cancer Screening - 12 Months | Low Satisfaction | 175 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision Scale- Cancer Screening (Data Reported in Outcome Measure #10) | Colorectal Cancer Screening - Baseline | Low Satisfaction | 196 Participants |
Secondary
Satisfaction With Decision Scale- Mental Health (Data Reported in Secondary Outcome Measure #10)
The Satisfaction with Decision Scale is a 6-item measure that uses a five-point Likert-type scale; it is grounded in a conceptual model of an effective decision, i.e., one that is informed, consistent with the decision-maker's values, and behaviorally implemented. This scale has been tailored to healthcare decisions to have mental health care.The satisfaction with decision scale of mental health and its continuous summary score was converted into two categories (high satisfaction and low satisfaction) using the median as the cutoff point.
Time frame: 12 months
| Arm | Measure | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|
| Collaborative Care Intervention (CCI) | Satisfaction With Decision Scale- Mental Health (Data Reported in Secondary Outcome Measure #10) | High Satisfaction | 129 Participants |
| Collaborative Care Intervention (CCI) | Satisfaction With Decision Scale- Mental Health (Data Reported in Secondary Outcome Measure #10) | Low Satisfaction | 175 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision Scale- Mental Health (Data Reported in Secondary Outcome Measure #10) | High Satisfaction | 128 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision Scale- Mental Health (Data Reported in Secondary Outcome Measure #10) | Low Satisfaction | 191 Participants |
Comparison: Satisfaction with decision to participate in Mental Health Care at 12 months. Recoding of the continuous measure was based on quartiles.p-value: 0.56Chi-squared
Secondary
Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale
The Satisfaction with Decision Scale is a 6-item measure that uses a five-point Likert-type scale; it is grounded in a conceptual model of an effective decision, i.e., one that is informed, consistent with the decision-maker's values, and behaviorally implemented. This scale has been tailored to healthcare decisions to receive treatment for emotional or mental health and to have cervical, breast, and colon cancer screening.The continuous summary score was converted into two categories using the median as a cut point. The two categories are high satisfaction and low satisfaction.
Time frame: Baseline, 6 months and 12 months
Population: This data is collected at baseline, 6 months and 12 months for 3 different instruments. Not all participants completed all instruments at all time points.
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Collaborative Care Intervention (CCI) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Cervical Cancer Screening - 6 months | High Satisfaction | 99 Participants |
| Collaborative Care Intervention (CCI) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Colorectal Cancer Screening - 12 months | High Satisfaction | 135 Participants |
| Collaborative Care Intervention (CCI) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Breast Cancer Screening - Baseline | High Satisfaction | 186 Participants |
| Collaborative Care Intervention (CCI) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Breast Cancer Screening - 6 months | Low Satisfaction | 151 Participants |
| Collaborative Care Intervention (CCI) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Cervical Cancer Screening - Baseline | High Satisfaction | 147 Participants |
| Collaborative Care Intervention (CCI) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Cervical Cancer Screening - 6 months | Low Satisfaction | 122 Participants |
| Collaborative Care Intervention (CCI) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Cervical Cancer Screening - 12 Months | High Satisfaction | 107 Participants |
| Collaborative Care Intervention (CCI) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Cervical Cancer Screening - 12 Months | Low Satisfaction | 119 Participants |
| Collaborative Care Intervention (CCI) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Mental Health Care - 12 Months | High Satisfaction | 129 Participants |
| Collaborative Care Intervention (CCI) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Mental Health Care - 12 Months | Low Satisfaction | 175 Participants |
| Collaborative Care Intervention (CCI) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Colorectal Cancer Screening - Baseline | High Satisfaction | 161 Participants |
| Collaborative Care Intervention (CCI) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Colorectal Cancer Screening - 6 months | High Satisfaction | 112 Participants |
| Collaborative Care Intervention (CCI) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Colorectal Cancer Screening - 6 months | Low Satisfaction | 183 Participants |
| Collaborative Care Intervention (CCI) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Colorectal Cancer Screening - 12 months | Low Satisfaction | 170 Participants |
| Collaborative Care Intervention (CCI) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Breast Cancer Screening - Baseline | Low Satisfaction | 188 Participants |
| Collaborative Care Intervention (CCI) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Breast Cancer Screening - 6 months | High Satisfaction | 147 Participants |
| Collaborative Care Intervention (CCI) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Breast Cancer Screening - 12 months | High Satisfaction | 150 Participants |
| Collaborative Care Intervention (CCI) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Breast Cancer Screening - 12 months | Low Satisfaction | 157 Participants |
| Collaborative Care Intervention (CCI) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Cervical Cancer Screening - Baseline | Low Satisfaction | 148 Participants |
| Collaborative Care Intervention (CCI) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Colorectal Cancer Screening - Baseline | Low Satisfaction | 212 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Breast Cancer Screening - 6 months | Low Satisfaction | 158 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Colorectal Cancer Screening - Baseline | Low Satisfaction | 196 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Colorectal Cancer Screening - 6 months | High Satisfaction | 131 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Cervical Cancer Screening - Baseline | High Satisfaction | 152 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Breast Cancer Screening - Baseline | High Satisfaction | 192 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Colorectal Cancer Screening - 6 months | Low Satisfaction | 170 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Colorectal Cancer Screening - 12 months | High Satisfaction | 148 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Cervical Cancer Screening - 6 months | High Satisfaction | 101 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Breast Cancer Screening - 12 months | High Satisfaction | 160 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Cervical Cancer Screening - 6 months | Low Satisfaction | 130 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Colorectal Cancer Screening - 12 months | Low Satisfaction | 175 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Cervical Cancer Screening - 12 Months | High Satisfaction | 120 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Cervical Cancer Screening - Baseline | Low Satisfaction | 142 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Cervical Cancer Screening - 12 Months | Low Satisfaction | 131 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Breast Cancer Screening - Baseline | Low Satisfaction | 184 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Mental Health Care - 12 Months | High Satisfaction | 128 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Breast Cancer Screening - 12 months | Low Satisfaction | 163 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Mental Health Care - 12 Months | Low Satisfaction | 191 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Breast Cancer Screening - 6 months | High Satisfaction | 145 Participants |
| Prevention Care Management (PCM) | Satisfaction With Decision to Participate in Screening and Mental Health Care as Assessed by Decision Scale | Colorectal Cancer Screening - Baseline | High Satisfaction | 180 Participants |
Comparison: Satisfaction with decision to participate in breast cancer screening at 6 months.p-value: 0.72Chi-squared
Comparison: Satisfaction with decision to participate in colorectal cancer screening at 6 months.p-value: 0.17Chi-squared
Comparison: Satisfaction with decision to participate in colorectal cancer screening at 12 months.p-value: 0.69Chi-squared
Comparison: Satisfaction with decision to participate in breast cancer screening at baseline.p-value: 0.72Chi-squared
Comparison: Satisfaction with decision to participate in colorectal cancer screening at baseline.p-value: 0.2Chi-squared
Comparison: Satisfaction with decision to participate in breast cancer screening at 12 months.p-value: 0.87Chi-squared
Comparison: Satisfaction with decision to participate in cervical cancer screening at baseline.p-value: 0.65Chi-squared
Comparison: Satisfaction with decision to participate in cervical cancer screening at 6 months.p-value: 0.82Chi-squared
Comparison: Satisfaction with decision to participate in cervical cancer screening at 12 months.p-value: 0.92Chi-squared
Comparison: Satisfaction with decision to participate in Mental Health Care at 12 months.p-value: 0.56Chi-squared
Secondary
Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization
This 5-item scale measures a sense of perceived self-efficacy associated with accessing and paying for the three different types of cancer screening and utilization of needed mental health services. The continuous study score was converted into 4 categories using quartiles as cut points. The 4 categories are high self-efficacy, moderate self- efficacy, minimal self-efficacy and low self-efficacy.
Time frame: Baseline, 6 months and 12 months
Population: Data are collected at baseline, 6 months and 12 months. Not all participants completed the assessment at all time points.
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Collaborative Care Intervention (CCI) | Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization | 12 months | Moderate Self-Efficacy | 81 Participants |
| Collaborative Care Intervention (CCI) | Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization | 12 months | Minimal Self-Efficacy | 77 Participants |
| Collaborative Care Intervention (CCI) | Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization | 12 months | Low Self-Efficacy | 77 Participants |
| Collaborative Care Intervention (CCI) | Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization | Baseline | High Self-Efficacy | 98 Participants |
| Collaborative Care Intervention (CCI) | Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization | Baseline | Moderate Self-Efficacy | 87 Participants |
| Collaborative Care Intervention (CCI) | Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization | Baseline | Minimal Self-Efficacy | 90 Participants |
| Collaborative Care Intervention (CCI) | Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization | Baseline | Low Self-Efficacy | 98 Participants |
| Collaborative Care Intervention (CCI) | Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization | 6 months | High Self-Efficacy | 70 Participants |
| Collaborative Care Intervention (CCI) | Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization | 6 months | Moderate Self-Efficacy | 68 Participants |
| Collaborative Care Intervention (CCI) | Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization | 6 months | Minimal Self-Efficacy | 77 Participants |
| Collaborative Care Intervention (CCI) | Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization | 6 months | Low Self-Efficacy | 83 Participants |
| Collaborative Care Intervention (CCI) | Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization | 12 months | High Self-Efficacy | 71 Participants |
| Prevention Care Management (PCM) | Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization | 6 months | Low Self-Efficacy | 80 Participants |
| Prevention Care Management (PCM) | Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization | 12 months | Moderate Self-Efficacy | 81 Participants |
| Prevention Care Management (PCM) | Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization | Baseline | Low Self-Efficacy | 101 Participants |
| Prevention Care Management (PCM) | Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization | 12 months | Minimal Self-Efficacy | 79 Participants |
| Prevention Care Management (PCM) | Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization | 6 months | Minimal Self-Efficacy | 74 Participants |
| Prevention Care Management (PCM) | Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization | 12 months | Low Self-Efficacy | 85 Participants |
| Prevention Care Management (PCM) | Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization | 6 months | High Self-Efficacy | 74 Participants |
| Prevention Care Management (PCM) | Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization | Baseline | High Self-Efficacy | 87 Participants |
| Prevention Care Management (PCM) | Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization | 12 months | High Self-Efficacy | 79 Participants |
| Prevention Care Management (PCM) | Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization | Baseline | Moderate Self-Efficacy | 98 Participants |
| Prevention Care Management (PCM) | Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization | 6 months | Moderate Self-Efficacy | 76 Participants |
| Prevention Care Management (PCM) | Self-efficacy and Behavior Towards Cancer Screening/Mental Health Utilization | Baseline | Minimal Self-Efficacy | 87 Participants |
Comparison: Self-efficacy at baseline.Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.7Chi-squared
Comparison: Self-efficacy at 6 months. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.89Chi-squared
Comparison: Self-efficacy at 12 months. Continuous summary score was converted into 4 categories using quartiles as cut-points.p-value: 0.95Chi-squared